US Patent Issued to Regeneron Pharmaceuticals, MEDIGENE IMMUNOTHERAPIES on March 31 for "Engineered T cells" (American, German Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,136, issued on March 31, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.) and MEDIGENE IMMUNOTHERAPIES GMBH (Planegg-Martinsried, Germany).

"Engineered T cells" was invented by Jasdeep Mann (Lake Forest Park, Wash.), Christian Ellinger (Munich), Daniel Sommermeyer (Munich) and Benjamin Boyerinas (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides improved compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith....